Bhagiradha Chemicals & Industri Share Price
Sector: Chemical Manufacturing
298.45 +3.75 (1.27%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
295.30
Today’s High
301.00
52 Week Low
242.80
52 Week High
448.00
298.00 +2.60 (0.88%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
293.05
Today’s High
301.20
52 Week Low
242.95
52 Week High
447.70
Key Metrics
- Market Cap (In Cr) 3874.58
- Beta 1.02
- Div. Yield (%) 0.05
- P/B 5.68
- TTM P/E 246.06
- Sector P/E 17.63
- D/E 0
- Open Price 295.3
- Prev Close 294.7
Bhagiradha Chemicals & Industri Analysis
Price Analysis
-
1 Week-0.2%
-
3 Months7.44%
-
6 Month0.72%
-
YTD-0.4%
-
1 Year17.45%
Risk Meter
- 36% Low risk
- 36% Moderate risk
- 36% Balanced Risk
- 36% High risk
- 36% Extreme risk
Bhagiradha Chemicals & Industri News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 29 May 2025Inside Radhakishan Damani’s winning portfolio: Two smallcap stocks to watch
7 min read . 09 Dec 2024Stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks
2 min read . 25 Jul 2024Q3 results this week: L&T Finance, Axis Bank, Yes Bank, Adani Power and more
5 min read . 21 Jan 2024Bhagiradha Chemicals & Industri Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 440.47
- Selling/ General/ Admin Expenses Total
- 40.68
- Depreciation/ Amortization
- 13.86
- Other Operating Expenses Total
- 84.71
- Total Operating Expense
- 417.39
- Operating Income
- 23.08
- Net Income Before Taxes
- 25.25
- Net Income
- 13.86
- Diluted Normalized EPS
- 1.14
- Period
- 2025
- Total Assets
- 933.15
- Total Liabilities
- 250.93
- Total Equity
- 682.22
- Tangible Book Valueper Share Common Eq
- 52.38
- Period
- 2025
- Cashfrom Operating Activities
- -52.8
- Cashfrom Investing Activities
- -199.99
- Cashfrom Financing Activities
- 271.66
- Net Changein Cash
- 18.87
- Period
- 2024
- Total Revenue
- 407.65
- Selling/ General/ Admin Expenses Total
- 46.78
- Depreciation/ Amortization
- 10.98
- Other Operating Expenses Total
- 12.71
- Total Operating Expense
- 375.71
- Operating Income
- 31.93
- Net Income Before Taxes
- 26.92
- Net Income
- 18.22
- Diluted Normalized EPS
- 1.61
- Period
- 2024
- Total Assets
- 576.04
- Total Liabilities
- 162.33
- Total Equity
- 413.71
- Tangible Book Valueper Share Common Eq
- 39.54
- Period
- 2024
- Cashfrom Operating Activities
- 34.29
- Cashfrom Investing Activities
- -120.62
- Cashfrom Financing Activities
- 88.31
- Net Changein Cash
- 1.99
- Period
- 2023
- Total Revenue
- 502.09
- Selling/ General/ Admin Expenses Total
- 43.15
- Depreciation/ Amortization
- 9.81
- Other Operating Expenses Total
- 11.97
- Total Operating Expense
- 434.57
- Operating Income
- 67.52
- Net Income Before Taxes
- 63.78
- Net Income
- 45.15
- Diluted Normalized EPS
- 4.44
- Period
- 2023
- Total Assets
- 446.91
- Total Liabilities
- 133.66
- Total Equity
- 313.25
- Tangible Book Valueper Share Common Eq
- 30.06
- Period
- 2023
- Cashfrom Operating Activities
- 13.89
- Cashfrom Investing Activities
- -59.61
- Cashfrom Financing Activities
- 46.47
- Net Changein Cash
- 0.73
- Period
- 2022
- Total Revenue
- 435.67
- Selling/ General/ Admin Expenses Total
- 35.81
- Depreciation/ Amortization
- 8.73
- Other Operating Expenses Total
- 11.24
- Total Operating Expense
- 376.12
- Operating Income
- 59.55
- Net Income Before Taxes
- 51.31
- Net Income
- 35.75
- Diluted Normalized EPS
- 3.77
- Period
- 2022
- Total Assets
- 342.02
- Total Liabilities
- 152.15
- Total Equity
- 189.87
- Tangible Book Valueper Share Common Eq
- 19.97
- Period
- 2022
- Cashfrom Operating Activities
- 6.61
- Cashfrom Investing Activities
- -17.12
- Cashfrom Financing Activities
- 12.42
- Net Changein Cash
- 1.88
- Period
- 2021
- Total Revenue
- 317.9
- Selling/ General/ Admin Expenses Total
- 34.8
- Depreciation/ Amortization
- 8.17
- Other Operating Expenses Total
- 1.92
- Total Operating Expense
- 278.12
- Operating Income
- 39.77
- Net Income Before Taxes
- 32.14
- Net Income
- 23.32
- Diluted Normalized EPS
- 2.38
- Period
- 2021
- Total Assets
- 273.17
- Total Liabilities
- 117.49
- Total Equity
- 155.69
- Tangible Book Valueper Share Common Eq
- 16.37
- Period
- 2021
- Cashfrom Operating Activities
- 3.56
- Cashfrom Investing Activities
- -20.76
- Cashfrom Financing Activities
- 14.8
- Net Changein Cash
- -2.4
- Period
- 2020
- Total Revenue
- 245.67
- Selling/ General/ Admin Expenses Total
- 48.27
- Depreciation/ Amortization
- 6.66
- Other Operating Expenses Total
- 1.54
- Total Operating Expense
- 232.93
- Operating Income
- 12.73
- Net Income Before Taxes
- 8.92
- Net Income
- 6.51
- Diluted Normalized EPS
- 0.5
- Period
- 2020
- Total Assets
- 225.26
- Total Liabilities
- 93.02
- Total Equity
- 132.24
- Tangible Book Valueper Share Common Eq
- 13.89
- Period
- 2020
- Cashfrom Operating Activities
- 48.16
- Cashfrom Investing Activities
- -38.6
- Cashfrom Financing Activities
- -9.12
- Net Changein Cash
- 0.44
- Period
- 2019
- Total Revenue
- 383.98
- Selling/ General/ Admin Expenses Total
- 18.25
- Depreciation/ Amortization
- 4.82
- Other Operating Expenses Total
- 21.87
- Total Operating Expense
- 347.51
- Operating Income
- 36.47
- Net Income Before Taxes
- 29.12
- Net Income
- 18.29
- Diluted Normalized EPS
- 1.93
- Period
- 2019
- Total Assets
- 273.62
- Total Liabilities
- 145.52
- Total Equity
- 128.1
- Tangible Book Valueper Share Common Eq
- 13.45
- Period
- 2019
- Cashfrom Operating Activities
- 48.87
- Cashfrom Investing Activities
- -37.62
- Cashfrom Financing Activities
- -12.38
- Net Changein Cash
- -1.13
- Period
- 2025-03-31
- Total Revenue
- 122.62
- Selling/ General/ Admin Expenses Total
- 10.99
- Depreciation/ Amortization
- 3.6
- Other Operating Expenses Total
- 21.85
- Total Operating Expense
- 120.14
- Operating Income
- 2.48
- Net Income Before Taxes
- 2.25
- Net Income
- -0.88
- Diluted Normalized EPS
- -0.08
- Period
- 2025-03-31
- Total Assets
- 933.15
- Total Liabilities
- 250.93
- Total Equity
- 682.22
- Tangible Book Valueper Share Common Eq
- 52.38
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -52.8
- Cashfrom Investing Activities
- -199.99
- Cashfrom Financing Activities
- 271.66
- Net Changein Cash
- 18.87
- Period
- 2024-12-31
- Total Revenue
- 102.73
- Selling/ General/ Admin Expenses Total
- 9.81
- Depreciation/ Amortization
- 3.61
- Other Operating Expenses Total
- 21.98
- Total Operating Expense
- 97.18
- Operating Income
- 5.55
- Net Income Before Taxes
- 5.55
- Net Income
- 3.59
- Diluted Normalized EPS
- 0.26
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 103.73
- Selling/ General/ Admin Expenses Total
- 10.25
- Depreciation/ Amortization
- 3.41
- Other Operating Expenses Total
- 20.7
- Total Operating Expense
- 97.43
- Operating Income
- 6.3
- Net Income Before Taxes
- 7.78
- Net Income
- 5.44
- Diluted Normalized EPS
- 0.42
- Period
- 2024-09-30
- Total Assets
- 833.36
- Total Liabilities
- 206.35
- Total Equity
- 627.01
- Tangible Book Valueper Share Common Eq
- 50.19
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -34.06
- Cashfrom Investing Activities
- -175.69
- Cashfrom Financing Activities
- 226.24
- Net Changein Cash
- 16.49
- Period
- 2024-06-30
- Total Revenue
- 111.39
- Selling/ General/ Admin Expenses Total
- 9.63
- Depreciation/ Amortization
- 3.25
- Other Operating Expenses Total
- 20.19
- Total Operating Expense
- 102.64
- Operating Income
- 8.75
- Net Income Before Taxes
- 9.67
- Net Income
- 5.71
- Diluted Normalized EPS
- 0.49
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 111.25
- Selling/ General/ Admin Expenses Total
- 8.81
- Depreciation/ Amortization
- 2.85
- Other Operating Expenses Total
- 22.35
- Total Operating Expense
- 100.02
- Operating Income
- 11.23
- Net Income Before Taxes
- 10.56
- Net Income
- 7.22
- Diluted Normalized EPS
- 0.56
- Period
- 2024-03-31
- Total Assets
- 576.04
- Total Liabilities
- 162.33
- Total Equity
- 413.71
- Tangible Book Valueper Share Common Eq
- 39.54
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 34.29
- Cashfrom Investing Activities
- -120.62
- Cashfrom Financing Activities
- 88.31
- Net Changein Cash
- 1.99
- Period
- 2023-12-31
- Total Revenue
- 74.37
- Selling/ General/ Admin Expenses Total
- 8.32
- Depreciation/ Amortization
- 2.68
- Other Operating Expenses Total
- 22.02
- Total Operating Expense
- 68.78
- Operating Income
- 5.59
- Net Income Before Taxes
- 4.79
- Net Income
- 3.32
- Diluted Normalized EPS
- 0.28
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Bhagiradha Chemicals & Industri Technical
Moving Average
SMA
- 5 Day296.43
- 10 Day299.08
- 20 Day300.5
- 50 Day297.9
- 100 Day294.05
- 300 Day316.18
Bhagiradha Chemicals & Industri Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Neogen Chemicals
- 1616.05
- -14.25
- -0.87
- 2414.9
- 1397.45
- 4270.74
- Nacl Industries
- 207.8
- 9.85
- 4.98
- 220.1
- 48.6
- 4144.35
- Bhagiradha Chemicals & Industri
- 298.45
- 3.75
- 1.27
- 448
- 242.8
- 3874.58
- Rossari Biotech
- 682.35
- 3.85
- 0.57
- 966
- 568.05
- 3769.88
- Vishnu Chemicals
- 536.7
- -16.8
- -3.04
- 586
- 340
- 3612.81
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Neogen Chemicals
- 96.56
- 5.46
- 8.4
- 6.6
- Nacl Industries
- -
- 9.33
- 2.86
- 0.86
- Bhagiradha Chemicals & Industri
- 259.12
- 5.61
- 9.21
- 6.48
- Rossari Biotech
- 27.55
- 3.17
- 14.11
- 7.12
- Vishnu Chemicals
- 28.82
- 4.03
- 22.52
- 8.28
Bhagiradha Chemicals & Industri Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-25
- Audited Results & Final Dividend
- 13-Feb-25
- Quarterly Results & Others
- 04-Jan-25
- Others
- 12-Nov-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 24-May-24
- Audited Results, Dividend & A.G.M.
- 05-Mar-24
- Stock Split
- 27-Jan-24
- Quarterly Results
- 17-Nov-23
- Others
- 04-Nov-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 22-Aug-25
- 28-May-25
- AGM
- 09-Aug-24
- 22-Jun-24
- AGM
- 09-Aug-24
- 27-May-24
- AGM
- 12-Apr-24
- 05-Mar-24
- POM
- 28-Jan-24
- 27-Dec-23
- POM
- 27-Jan-24
- 26-Dec-23
- POM
- 04-Nov-23
- 13-Oct-23
- EGM
- 28-Oct-23
- 26-Sept-23
- POM
- 27-Oct-23
- 25-Sept-23
- POM
- 12-Aug-22
- 26-May-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-25
- 14-Aug-25
- -
- 0.15
- 24-May-24
- -
- 02-Aug-24
- 0.1
- 15-May-23
- -
- 27-Jul-23
- 3
- 01-Nov-22
- 17-Nov-22
- 16-Nov-22
- 1
- 26-May-22
- -
- 04-Aug-22
- 2
- 26-Oct-21
- 12-Nov-21
- 11-Nov-21
- 1

- Ex-Splits
- Old FV
- New FV
- Description
- 02-May-24
- 10
- 1
- Stock split from Rs. 10/- to Re. 1/-.
- Announced on
- Record Date
- Ex-Rights Date
- Ratio
- FV
- Premium
- Description
- 14-Dec-21
- 09-Apr-22
- 07-Apr-22
- 4:17
- 10
- 390
- Rights issue of equity shares of Rs. 10/- each in the ratio of 4:17 @ premium of Rs. 390/-